Published in Med Decis Making on June 23, 1998
Measuring paternal discrepancy and its public health consequences. J Epidemiol Community Health (2005) 2.30
Impact of gene patents and licensing practices on access to genetic testing for cystic fibrosis. Genet Med (2010) 1.36
The translational potential of research on the ethical, legal, and social implications of genomics. Genet Med (2014) 0.82
Response rates to mail surveys published in medical journals. J Clin Epidemiol (1997) 21.55
Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial. JAMA (1999) 11.19
How do financial incentives affect physicians' clinical decisions and the financial performance of health maintenance organizations? N Engl J Med (1989) 5.77
Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes. Methods Enzymol (1974) 5.46
Estimating hospital costs. A multiple-output analysis. J Health Econ (1986) 3.09
Organization of the rat gamma-fibrinogen gene: alternative mRNA splice patterns produce the gamma A and gamma B (gamma ') chains of fibrinogen. Cell (1982) 2.94
Mortality and duration of hemodialysis treatment. JAMA (1991) 2.94
Physician response to fee changes with multiple payers. J Health Econ (1991) 2.92
Promoter region of interleukin-2 gene undergoes chromatin structure changes and confers inducibility on chloramphenicol acetyltransferase gene during activation of T cells. Mol Cell Biol (1986) 2.76
Medical staff characteristics and hospital costs. J Hum Resour (1978) 2.69
Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies. N Engl J Med (1991) 2.46
Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura. N Engl J Med (1990) 2.43
Knowing for the sake of knowing: the value of prognostic information. Med Decis Making (1990) 2.27
Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone. Br J Pharmacol (2008) 2.13
Access to kidney transplantation. Has the United States eliminated income and racial differences? Arch Intern Med (1988) 2.11
A re-examination of the meaning and importance of supplier-induced demand. J Health Econ (1994) 2.08
Diagnosis of posttransplantation lymphoproliferative disorder by endomyocardial biopsy in a cardiac allograft recipient. J Heart Lung Transplant (1994) 2.04
Cognitive processes and the decisions of some parents to forego pertussis vaccination for their children. J Clin Epidemiol (1996) 2.04
Predictors of type of vascular access in hemodialysis patients. JAMA (1996) 2.00
Making sense out of utilization data. Med Care (1975) 1.98
Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol Biochem Behav (1994) 1.90
Identification of a zinc finger protein that inhibits IL-2 gene expression. Science (1991) 1.82
Competition and efficiency in the end stage renal disease program. J Health Econ (1983) 1.79
Reporting the results of cystic fibrosis carrier screening. Am J Obstet Gynecol (1993) 1.78
Taxation, health insurance, and market failure in the medical economy. J Econ Lit (1986) 1.76
In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides. Proc Natl Acad Sci U S A (1992) 1.67
Molecular cloning of cDNA for the alpha, beta, and gamma chains of rat fibrinogen. A family of coordinately regulated genes. J Biol Chem (1981) 1.62
Tax credits for health insurance and medical savings accounts. Health Aff (Millwood) (1995) 1.62
Specificity in the association of glyceraldehyde 3-phosphate dehydrogenase with isolated human erythrocyte membranes. J Biol Chem (1973) 1.60
Reproducibility of synovial fluid analyses. A study among four laboratories. Arthritis Rheum (1986) 1.59
Outcome bias in decision evaluation. J Pers Soc Psychol (1988) 1.58
A new approach to hospital cost functions and some issues in revenue regulation. Health Care Financ Rev (1983) 1.58
Pregnancy outcome of patients with uncorrected uterine anomalies managed in a high-risk obstetric setting. Obstet Gynecol (1990) 1.57
Toward new typologies for HMOs. Milbank Q (1990) 1.56
Survival analysis of patients undergoing dialysis. JAMA (1987) 1.53
Evolution and organization of the fibrinogen locus on chromosome 4: gene duplication accompanied by transposition and inversion. Proc Natl Acad Sci U S A (1985) 1.49
Omission bias and pertussis vaccination. Med Decis Making (1994) 1.48
Evolution and structure of the fibrinogen genes. Random insertion of introns or selective loss? J Mol Biol (1985) 1.47
Regression and inhibition of sarcoma growth by interference with a radiosensitive T-cell population. J Exp Med (1978) 1.46
Partial mRNA sequences for human A alpha, B beta, and gamma fibrinogen chains: evolutionary and functional implications. Proc Natl Acad Sci U S A (1983) 1.44
Assessing physicians' estimates of the probability of coronary artery disease: the influence of patient characteristics. Med Decis Making (1992) 1.42
Management of a patient with atrioventricular septal defect and severe pulmonary hypertension undergoing major orthopedic surgery. J Cardiothorac Vasc Anesth (2000) 1.39
The illusion of deterministic rules. Ann Intern Med (1997) 1.39
Contractual arrangements between HMOs and primary care physicians: three-tiered HMOs and risk pools. Med Care (1992) 1.35
Cation-impermeable inside-out and right-side-out vesicles from human erythrocyte membranes. Nat New Biol (1972) 1.34
Patient compliance with antihypertensive medication. Am J Public Health (1980) 1.34
Why some health policies don't make sense at the bedside. Ann Intern Med (1995) 1.30
Structure of the human gamma-fibrinogen gene. Alternate mRNA splicing near the 3' end of the gene produces gamma A and gamma B forms of gamma-fibrinogen. J Biol Chem (1984) 1.30
Frequent incidence of somatic mutations in translocated BCL2 oncogenes of non-Hodgkin's lymphomas. Blood (1992) 1.29
Factors affecting the use of physician services in a rural community. Am J Public Health (1976) 1.29
Health maintenance organizations and hospital quality for coronary artery bypass surgery. Med Care Res Rev (1999) 1.25
Advantages of firefly luciferase as a reporter gene: application to the interleukin-2 gene promoter. Anal Biochem (1989) 1.24
Nonprofit firms in medical markets. Am Econ Rev (1987) 1.22
What is unnecessary surgery? Milbank Mem Fund Q Health Soc (1979) 1.20
First-cycle blood counts and subsequent neutropenia, dose reduction, or delay in early-stage breast cancer therapy. J Clin Oncol (1998) 1.19
What is adverse about adverse selection? Adv Health Econ Health Serv Res (1985) 1.19
The impact of computer-assisted test interpretation on physician decision making: the case of electrocardiograms. Med Decis Making (1997) 1.18
Prompt diagnosis of ectopic pregnancy in an emergency department setting. Obstet Gynecol (1994) 1.18
The Medicare cost of renal dialysis. Evidence from a statistical cost function. Med Care (1992) 1.17
The rat fibrinogen genes. Linkage of the A alpha and gamma chain genes. J Biol Chem (1983) 1.17
Expression of the smooth muscle myosin heavy chain gene is regulated by a negative-acting GC-rich element located between two positive-acting serum response factor-binding elements. J Biol Chem (1997) 1.16
Comorbidity-adjusted complication risk: a new outcome quality measure. Med Care (1996) 1.16
Effect of dialyzer reuse on survival of patients treated with hemodialysis. JAMA (1996) 1.13
Training in molecular pathology. Hum Pathol (1995) 1.13
Incentive effects of medical malpractice. The effects of malpractice litigation on physicians' fees and incomes. Am Econ Rev (1990) 1.12
Coordinate accumulation of the mRNAs for the alpha, beta, and gamma chains of rat fibrinogen following defibrination. J Biol Chem (1982) 1.11
Is cream-skimming a problem for the competitive medical market? J Health Econ (1984) 1.10
Neural tube defects: issues in prenatal diagnosis and counselling. Obstet Gynecol (1986) 1.08
Returns on equity for not-for-profit hospitals. Health Serv Res (1986) 1.07
Two regions within the human IL-2 gene promoter are important for inducible IL-2 expression. J Immunol (1988) 1.06
Hepatosplenic gammadelta T-cell lymphoma: ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation. Hum Pathol (1997) 1.05
Hospital output forecasts and the cost of empty hospital beds. Health Serv Res (1986) 1.05
Analysis of capacity decisions for progressive patient care hospital facilities. Health Serv Res (1980) 1.05
Health maintenance organization penetration and the practice location choices of new physicians: a study of large metropolitan areas in the United States. Med Care (1998) 1.05
Absence of t(14;18) major and minor breakpoints and of Bcl-2 protein overproduction in Reed-Sternberg cells of Hodgkin's disease. Am J Pathol (1991) 1.05
Biologic and therapeutic significance of MYB expression in human melanoma. Proc Natl Acad Sci U S A (1994) 1.04
A stochastic service network model with application to hospital facilities. Oper Res (1981) 1.04
Recurrence rate for de novo 21q21q translocation Down syndrome: a study of 112 families. Am J Med Genet (1984) 1.03
The use of an information system for community health services planning and management. Med Care (1975) 1.03
Effects of alpha- and beta-receptor blockade on systolic time intervals. Eur J Clin Pharmacol (1974) 1.03
Market power, monopsony, and health insurance markets. J Health Econ (1988) 1.03
Phosphorylation of the rRNA transcription factor upstream binding factor promotes its association with TATA binding protein. Proc Natl Acad Sci U S A (1998) 1.02
Novel cationic trypsinogen (PRSS1) N29T and R122C mutations cause autosomal dominant hereditary pancreatitis. Gut (2002) 1.01
Human erythrocyte galactokinase and galactose-1-phosphate uridylyltransferase: a population survey. Am J Hum Genet (1975) 1.00
Determinants of priority for risk reduction: the role of worry. Risk Anal (2000) 0.99
Neonatal morbidity in pregnancy complicated by diabetes mellitus: predictive value of maternal glycemic profiles. Am J Obstet Gynecol (1987) 0.99
Derived thresholds. Determining the diagnostic probabilities at which clinicians initiate testing and treatment. Med Decis Making (1983) 0.99
Price of dialysis, unit staffing, and length of dialysis treatments. Am J Kidney Dis (1990) 0.98
Premium variation in the individual health insurance market. Int J Health Care Finance Econ (2001) 0.98
The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease. J Clin Oncol (1986) 0.97
Galactose tolerance studies of individuals with reduced galactose pathway activity. Am J Hum Genet (1975) 0.97
Use of umbilical cord blood culture for detection of neonatal bacteremia. Obstet Gynecol (1981) 0.95
Financial incentives and drug spending in managed care. Health Aff (Millwood) (1999) 0.95
Molecular detection of a Yp/18 translocation in a 45,X holoprosencephalic male. Hum Genet (1988) 0.95
Genetic testing. Counseling, laboratory, and regulatory issues and the EUROPAC protocol for ethical research in multicenter studies of inherited pancreatic diseases. Med Clin North Am (2000) 0.95
The public's attitudes toward incentives for organ donation. Transplant Proc (1999) 0.95
Plaque-associated neuronal proteins: a recurrent motif in neuritic amyloid deposits throughout diverse cortical areas of the Alzheimer's disease brain. Exp Neurol (1994) 0.94